<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Pediatr Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">J Pediatr Genet</journal-id>
<journal-id journal-id-type="doi">10.1055/s-00029027</journal-id>
<journal-title-group>
<journal-title>Journal of Pediatric Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">2146-4596</issn>
<issn pub-type="epub">2146-460X</issn>
<publisher>
<publisher-name>Georg Thieme Verlag KG</publisher-name>
<publisher-loc>Stuttgart · New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27617129</article-id>
<article-id pub-id-type="pmc">4918723</article-id>
<article-id pub-id-type="doi">10.1055/s-0035-1564571</article-id>
<article-id pub-id-type="publisher-id">1508</article-id>
<article-categories>
<subj-group>
<subject>Review Article</subject>
</subj-group>
<series-title>Genetic Advances in Intellectual Disability</series-title>
<series-text>Guest Editor: Donatella Milani, MD</series-text>
</article-categories>
<title-group>
<article-title>Ultra-Rare Syndromes: The Example of Rubinstein–Taybi Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Spena</surname>
<given-names>Silvia</given-names>
</name>
<xref ref-type="aff" rid="AF1508-1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gervasini</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="AF1508-1">1</xref>
<xref ref-type="author-notes" rid="CO1508-1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Milani</surname>
<given-names>Donatella</given-names>
</name>
<xref ref-type="aff" rid="AF1508-2">2</xref>
</contrib>
</contrib-group>
<aff id="AF1508-1">
<label>1</label>
<institution>Medical Genetics, Department of Health Sciences, Università degli Studi di Milano, Milano, Italy</institution>
</aff>
<aff id="AF1508-2">
<label>2</label>
<institution>Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore, Policlinico, Milano, Italy</institution>
</aff>
<author-notes>
<corresp id="CO1508-1"><bold>Address for correspondence </bold>Cristina Gervasini, PhD <institution>Medical Genetics, Department of Health Sciences, Università degli Studi di Milano</institution><addr-line>via A. di Rudinì, 8, 20142 Milan</addr-line><country>Italy</country><email>cristina.gervasini@unimi.it</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2015</year>
</pub-date>
<volume>4</volume>
<issue>3</issue>
<fpage>177</fpage>
<lpage>186</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>4</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>5</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© Thieme Medical Publishers</copyright-statement>
</permissions>
<abstract>
<p>Rubinstein–Taybi syndrome (RSTS) is a rare, congenital, plurimalformative, and neurodevelopmental disorder. Clinical diagnosis can be complicated by the heterogeneous clinical presentation and the lack of a consensus list of diagnostic criteria, and it is confirmed by molecular tests in approximately 55 to 78% of cases. The etiology is partially known with mutations in two functionally related genes: <italic>CREBBP</italic> and <italic>EP300</italic>. Notwithstanding the knowledge on clinical, genetic, and allelic heterogeneity, no clear genotype–phenotype correlation has yet been established. Standardized guidelines for the management of pediatric patients are available and therapy for RSTS patients is currently only symptomatic. In this article, several clinic and genetic aspects of RSTS are critically reviewed.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Rubinstein–Taybi syndrome</kwd>
<kwd>clinical and molecular diagnosis</kwd>
<kwd>genotype–phenotype correlation</kwd>
<kwd>management</kwd>
<kwd>therapy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>